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Background: To explore the interobserver variability in the delineation of the tumour bed using seroma and surgical
clips based on the four-dimensional computed tomography (4DCT) scan for external-beam partial breast irradiation
(EB-PBI) during free breathing.
Methods: Patients with a seroma clarity score (SCS) 3 ~ 5 and ≥5 surgical clips in the lumpectomy cavity after
breast-conserving surgery who were recruited for EB-PBI underwent 4DCT simulation. Based on the ten sets of
4DCT images acquired, the tumour bed formed using the clips, the seroma, and both the clips and seroma (defined as
TBC, TBS and TBC+S, respectively) were delineated by five radiation oncologists using specific guidelines. The following
parameters were calculated to analyse interobserver variability: volume of the tumour bed (TBC, TBS, TBC+S), coefficient
of variation (COVC, COVS, COVC+S), and matching degree (MDC, MDS, MDC+S).
Results: The interobserver variability for TBC and TBC+S and for COVC and COVC+S were statistically significant (p = 0.021,
0.008, 0.002, 0.015). No significant difference was observed for TBS and COVS (p = 0.867, 0.061). Significant differences in
interobserver variability were observed for MDC vs MDS, MDC vs MDC+S, MDS vs MDC+S (p = 0.000, 0.032, 0.008), the
interobserver variability of MDS was smaller than that of MDC and MDC+S (MDS >MDC+S >MDC).
Conclusions: When the SCS was 3 ~ 5 points and the number of surgical clips was ≥5, interobserver variability was
minimal for the delineation of the tumour bed based on seroma.
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Breast-conserving therapy (BCT), which involves a wide
local excision followed by radiotherapy to the whole
breast, is the standard treatment for early-stage breast
cancer [1]. The efficacy of BCT for the treatment of early-
stage breast carcinoma has been established in multiple
randomised trials [2,3]. External-beam partial breast ir-
radiation (EB-PBI) has recently garnered increasing
interest [4,5]. Several studies reported that EB-PBI, which
delivers radiotherapy to the postoperative tumour bed
(TB) with a margin of adjacent breast tissue, could achieve* Correspondence: lijianbin@msn.com
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unless otherwise stated.excellent results in certain patients. However, there are
inherent challenges in defining accurate target volumes
for partial breast irradiation (PBI). Studies demonstrate
significant interobserver variability between radiation
oncologists in defining the lumpectomy cavity, indicat-
ing the need to improve the accuracy and consistency
in the delineation of the TB [6,7].
Surgical clips and seroma are important markers for
delineating the TB for EB-PBI [7,8]. Kirby et al. [7] reported
that the number of implanted markers influences the accur-
acy of target delineation and that five to six surgical clips
are preferable for TB delineation for PBI or breast boost
radiotherapy. Landis et al. [8] indicated that the shift of the
centre of mass (COM) decreased and the percent volume
overlap (PVO) increased significantly as the seroma clarityis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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metal clips, SCS, delineation experience and contouring
guidelines for the delineation of TB in CT images have
been investigated [6,7,9-11]. However, the effect of in-
terobserver variability on the delineation of the TB using
seroma and surgical clips based on 4DCT scan is not
clearly established. To investigate the impact of different
markers on interobserver variability in the delineation of
TB based on 4DCT scan for EB-PBI, we analysed the TB
delineated by five observers in this study based on clips,
seroma, and both clips and seroma.Methods
Patients
Twenty patients who underwent wide-local excision of
breast cancer with full-thickness unstitching of the exci-
sion cavity (10 left-sided and 10 right-sided lesions)
followed by EB-PBI between June 2009 and November
2013 were included in this study. To improve the delin-
eation accuracy and consistency, all of the enrolled pa-
tients had SCS 3 ~ 5 and ≥5 surgical clips to mark the
boundaries of the lumpectomy cavity. For every patient,
five or more roundish surgical clips with diameters of
2 mm were implanted. The surgical clips were fixed to
the superior, inferior, medial, lateral, and posterior walls
of the surgical cavity, respectively (median number: 6)
[12]. The average interval from lumpectomy to 4DCT
scan was 10 weeks (range, 3-16 weeks). All patients were
free of chronic lung diseases, and their ventilation
functions were normal. Written informed consent was
obtained from all patients with the approval of the In-
stitutional Review Board (Shandong Tumour Hospital
Ethics Committee).Four-dimensional CT image acquisition
All twenty patients were immobilised in the supine pos-
ition on a breast board using an arm support (with both
arms above the head to adequately expose the breast).
4DCT images and respiratory signals were acquired with
a thickness of 3 mm at the conclusion of the standard
CT simulation using a 16-slice Brilliance Big Bore CT
scanner (Philips Medical Systems, Inc., Cleveland, OH,
USA). The signals were sent to the scanner to label a
time tag on each CT image. GE Advantage 4D software
(General Electric Healthcare, Waukesha, WI, USA) sorted
the reconstructed 4DCT images into 10 respiratory phases
based on these tags, with 0% corresponding to end inhal-
ation (EI) and 50% corresponding to end exhalation (EE).
Then, the constructed 4DCT image sets were transferred
to the Eclipse treatment planning system (Eclipse™ 8.6;
Varian Medical Systems, Palo Alto, CA) for structure
delineation.Observers
Five observers specialising in radiation treatment of breast
carcinoma with more than five years of radiotherapy
experience performed the delineations.
Tumour bed delineation
The 10%~ 90% phases of the 4DCT images were registered
on the 0% phase images, which served as the basic phase
image. The tumour beds were delineated from the ten sets
of 4DCT images based on the clips, the seroma, and both
the clips and seroma (termed TBC, TBS, TBC+S, respect-
ively) according to a set of guidelines [13] (Figure 1). When
the TB was delineated based on clips, we adjusted the win-
dow level and width to minimise the impact of seroma for
contouring. All observers outlined a single test case that
was reviewed prior to commencing the study to ensure that
the guidelines were being followed.
Observation parameters
To quantify interobserver variability, the following pa-
rameters were calculated: the volume of TB (TBC, TBS,
TBC+S), which was an average value generated from the
ten contours of the registered images for each patient,
and the interobserver coefficient of variation (COVC,
COVS, COVC+S) for each patient. The COV was defined
as the ratio between the standard deviation and the aver-
age volume of TB. For TBC, TBS, and TBC+S, an evaluation
of the matching degree among the various observers in the
EE phase was also performed. For each patient, the ratio
between the intersection volume (the intersection among
the volumes delineated by the five observers) and the union
volume (the union among the volumes delineated by the
five observers) was calculated (termed MDC, MDS and
MDC+S, respectively) [14] (Figure 2). The volume variability
between the clips, the seroma, and both the clips and
seroma based on the same observer was also calculated.
Statistical analysis
SPSS 19.0 software was used for statistical analyses. A
normal distribution test and a test for homogeneity of
variance were performed. To investigate the interobserver
variability in the delineation of the TB based on different
makers in 4DCT images, a univariate analysis of variance
(ANOVA) was used to compare differences in the TB
(TBC, TBS, TBC+S), COV (COVC, COVS, COVC+S) and
MD (MDC, MDS, MDC+S) between observers. The volume
variability between the TBC, TBS and TBC+S was also com-
pared using ANOVA. P < 0.05 was considered significant.
Results
TB volume
The volumes of TBC, TBS and TBC+S are listed in Table 1.
The average volumes of TBC, TBS and TBC+S were
21.98 cc (range 8.70-45.13), 14.36 cc (range 3.14-41.80),
Figure 1 Single CT slice and volumetric image of one patient with delineated TBC (a), TBS (b) and TBC+S (c) of all 5 observers. TBC, the
TB delineated based on clips; TBS, the TB delineated based on the seroma; TBC+S, the TB delineated based on both seroma and clips.
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variability between the TBC, TBS and TBC+S was statistically
significant (p < 0.05) (Table 2). Furthermore, the average
duration from lumpectomy to 4DCT scan was 10 weeks
(range, 3-16). The volume of TBC was similar to that of
TBS for six patients during weeks 4-8, the TBC was less
than TBS in two patients during weeks 0-3, and the TBC
was larger than TBS for twelve patients during weeks 8-16.
The interobserver variability for TBC, TBS and TBC+S is
listed in Table 2. The interobserver variability for TBC and
TBC+S was statistically significant (p = 0.021, 0.008). How-
ever, the interobserver variability for TBS was not statisti-
cally significant (p = 0.867).
COV
The interobserver variability for COV is listed in Table 3.
The interobserver variability for COVC and COVC+S was
statistically significant (p = 0.002, 0.015), but the interob-
server variability for COVS was not statistically significant
(p = 0.061).
MD
Table 4 lists the differences in MD between the volumes
delineated based on clips, seroma, and both clips andseroma in the EE phase. The interobserver variability for
the MDC, MDS and MDC+S was statistically significant
(F = 16.866, p = 0.000). There were also significant differ-
ences between MDC and MDS, MDC and MDC+S, and
MDS and MDC+S (p = 0.000, 0.032, 0.008); the interob-
server variability for MDS was smaller than that of MDC
and MDC+S (MDS >MDC+S >MDC).
Discussion
The accuracy of target volume delineation is critical for
EB-PBI. The optimal target volume for EB-PBI remains
to be established. Most reports define the tumour exci-
sion cavity or postoperative seroma as the target volume
in treatment planning [7,8,15]. However, these studies
also reported significant interobserver variation in delin-
eating post-lumpectomy cavities. van Mourik et al. [16]
investigated breast target volume delineations among thir-
teen observers in eight patients. They reported that the
presence of clips or seroma reduced interobserver vari-
ability but that significant volumetric and spatial interob-
server variability was observed in clinical target volume
(CTV) even with the help of delineation guidelines.
Therefore, reducing interobserver variability is a pressing
issue. To improve delineation accuracy and consistency,
Figure 2 Mismatch between the TB delineated by five observers. The union volume is defined as the union of the five tumour beds, whereas the
intersection volume is the intersection between the five tumour beds.
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to mark the boundaries of the lumpectomy cavity.
Seroma clarity and volume in the lumpectomy cavity
decreased as a function of time from surgery to the CT
scan. The use of the CT-based seroma to guide the EB-PBI
target volume is difficult due to a lack of clearly defined
standards. Kader et al. [6] selected 205 women with early-
stage breast cancer to undergo planning CT after breast
conserving surgery and found that the mean seroma vol-
ume decreased from 47 cc to 30 cc during postoperative
weeks 3-8, stabilised during weeks 9-14 (mean 21 cc) and
was involuted beyond 14 weeks (mean 9 cc). In our study,
the average duration from lumpectomy to 4DCT scan was
10 weeks (range, 3-16). The volume of TBC approached
the volume of TBS for six patients during weeks 4-8, and
the TBC < TBS in two patients during weeks 0-3. However,
after 8 weeks, the volume of TBC was larger than that of
TBS for 12 patients. Therefore, given the magnitude and
time trends of seroma volume and clarity loss, the optimaltime to obtain the planning CT scan for PBI is within
8 weeks after surgery.
Surgical clips are not always consistent with the edge
of seroma and the boundary of the lumpectomy cavity
[13,17]. Ding et al [13] measured the three dimensional
displacements of the GTVC, the GTVs and the GTVC+S
and found that in the LR, AP and SI directions, the dis-
placements were 0.9 mm, 1.05 mm and 1.20 mm for
GTVC; 0.80 mm, 1.05 mm and 0.80 mm for GTVs; and
0.90 mm, 1.20 mm and 1.40 mm for GTVC+S, respectively.
In other words, the three dimensional displacements of
GTVC+S were greater than those of GTVC and GTVS.
Yang et al. [17] also measured the distance between surgi-
cal clips and the edge of the seroma in a coronal plane in
women who underwent wide local excision of breast
cancer and reported that the mean seroma edge ex-
tended beyond the clips by 0.3-0.5 cm. This study indi-
cates that the volume of TBC+S delineated by observers
was significantly larger than TBC and TBS. These results
Table 1 The volumes of TBC, TBS and TBC+S (cc)
Patients TBC TBS TBC+S
1 27.62(21.40-35.58) 10.28(9.16-11.09) 31.28(21.97-41.28)
2 30.20(24.22-32.13) 13.80(12.34-15.27) 32.58(24.93-36.33)
3 29.79(26.69-34.52) 24.01(21.33-25.93) 40.28(34.96-47.32)
4 45.13(42.98-47.03) 41.80(38.63-45.81) 55.80(48.73-67.71)
5 27.39(22.80-32.17) 14.48(12.38-19.49) 33.33(26.43-41.73)
6 24.94(20.59-31.99) 32.48(30.30-37.82) 47.61(44.20-59.24)
7 8.70(8.24-9.12) 6.40(5.60-8.13) 15.87(11.54-21.91)
8 16.91(14.17-22.80) 15.62(11.16-20.84) 19.14(17.55-20.01)
9 17.36(14.09-23.07) 13.03(10.77-16.64) 22.57(17.29-29.60)
10 19.43(16.62-24.45) 27.46(24.15-29.68) 40.21(34.14-47.77)
11 25.15(22.44-30.97) 14.46(13.08-17.61) 28.43(23.49-35.69)
12 24.26(21.78-30.37) 25.20(24.21-26.71) 33.87(31.53-40.34)
13 24.39(21.66-31.57) 8.38(6.58-11.50) 29.41(23.05-36.77)
14 15.02(11.93-23.00) 4.73(3.37-7.38) 17.64(12.88-24.60)
15 14.82(8.40-22.39) 8.22(6.26-9.25) 19.44(14.92-25.81)
16 16.89(13.07-26.14) 5.67(4.12-7.84) 20.09(12.57-28.15)
17 23.22(11.32-33.70) 4.44(3.89-4.97) 30.11(25.58-35.88)
18 15.68(12.31-22.72) 6.55(4.6-9.12) 19.19(13.37-25.41)
19 10.84(7.51-18.40) 3.14(2.49-4.5) 12.88(9.44-19.88)
20 21.83(16.64-28.61) 7.13(5.97-8.75) 26.16(20.08-33.18)
Mean 21.98 14.36 28.79
Abbreviations: TBC, the tumour bed delineated based on clips; TBS, the tumour
bed delineated based on the seroma; TBC+S, the tumour bed delineated based
on both seroma and clips.
Table 3 The interobserver variability for COV (%,Mean ± SD)
COVC COVS COVC+S
observer 1 4.08 ± 2.49 4.3 ± 2.13 3.81 ± 2.41
observer 2 4.04 ± 1.33 3.83 ± 2.04 3.23 ± 0.71
observer 3 4.24 ± 1.45 5.31 ± 2.85 4.61 ± 2.1
observer 4 2.66 ± 1.42 4.83 ± 2.30 2.69 ± 1.05
observer 5 5.10 ± 2.17 3.42 ± 1.55 3.52 ± 1.90
F 4.591 2.331 3.332
P 0.002 0.061 0.015
Abbreviations: COVC, coefficients of variability formed by TBC; COVS, coefficients
of variability formed by TBS; COVC+S, coefficients of variability formed by TBC+S.
Table 4 The differences in MD between the volumes
delineated based on clips, seroma and both clips and
seroma
patients MDc MDs MDc+s
1 0.30 0.41 0.29
2 0.37 0.51 0.39
3 0.37 0.45 0.39
4 0.31 0.69 0.49
5 0.38 0.46 0.39
6 0.38 0.58 0.37
7 0.40 0.44 0.30
8 0.34 0.46 0.49
9 0.36 0.50 0.34
10 0.36 0.63 0.46
11 0.43 0.52 0.40
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lumpectomy cavity from the time of lumpectomy to the
4DCT scan, as well as the variability between the TBC,
TBS, TBC+S regarding treatment margin.
Interestingly, we observed no significant differences
between observers for TBS (p = 0.867) and COVS (p =
0.061). This could be explained by the short average
duration from lumpectomy to planning CT and because
the SCS 3 ~ 5 in the lumpectomy cavity improved theTable 2 The interobserver variability for TBC, TBS and
TBC+S (cc,Mean ± SD)
TBC TBS TBC+S F P
observer 1 19.87 ± 9.14 14.16 ± 11.27 25.94 ± 12.19 5.798 0.005
observer 2 21.06 ± 8.75 14.26 ± 10.97 25.57 ± 10.76 6.815 0.002
observer 3 20.01 ± 7.8 12.78 ± 9.89 24.88 ± 10.43 8.312 0.001
observer 4 28.34 ± 6.91 14.07 ± 11.74 34.16 ± 11.13 19.565 0.000
observer 5 20.61 ± 9.07 16.55 ± 10.42 33.41 ± 13.80 12.001 0.000
F 3.644 0.315 3.053
P 0.008 0.867 0.021
Abbreviations: TBC, the tumour bed delineated based on clips; TBS, the tumour
bed delineated based on the seroma; TBC+S, the tumour bed delineated based
on both seroma and clips.visualisation of the surgical cavity. Landis et al. [8] re-
ported similar results in patients of SCS 4 and 5, as the
average COM shift was 3 mm and 2 mm, respectively,
and the PVO was 77% and 87%, respectively. Wong et al.
[18] also reported that after reviewing contouring guide-
lines, the differences in seroma target volume (STV),
CTV, and planning target volume (PTV) were no longer
statistically significant. Although Dzhugashvili et al. [9]12 0.45 0.59 0.51
13 0.37 0.37 0.39
14 0.29 0.43 0.30
15 0.32 0.61 0.44
16 0.31 0.41 0.39
17 0.18 0.31 0.55
18 0.24 0.48 0.42
19 0.25 0.30 0.34
20 0.27 0.63 0.45
x±s 0.33 ± 0.07 0.49 ± 0.11 0.40 ± 0.07
Abbreviations: MDC, the ratio between the intersection volume and the union
volume based on clips; MDS, the ratio between the intersection volume and
the union volume based on seroma; MDC+S, the ratio between the intersection
volume and the union volume based on both clips and seroma.
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significantly improved by the placement of surgical clips
within the lumpectomy cavity, a higher level of interob-
server concordance was observed by the five observers
when the SCS was 3 ~ 5 points in the lumpectomy cavity.
These data suggest that interobserver variability in the de-
lineation of TB based on seroma was not obvious when
the SCS was 3 ~ 5 points.
Although interobserver variability in the delineation of
the TB based on seroma was minimal, the clinical reality
could vary across regions. This was a retrospective study,
and all the enrolled patients had undergone wide-local
excision of breast cancer with full-thickness unstitching
of the excision cavity. Full thickness closure of the excision
cavity and oncoplastic surgical procedures are becoming
more widely practiced in some regions, and these surgical
methods could reduce the rate of seroma and its reliability
as a marker of the TB. Therefore, patients should be given
five or more surgical clips to reduce interobserver variabil-
ity when only clips are used in clinical practice. Moreover,
the placement of clips in the surgical cavity could be based
on guidelines, and the duration from lumpectomy to
4DCT scan could be shortened.
Hurkmans et al. [19] reported that intra- and, to a
greater extent, interobserver variability in the delineation
of breast target volume on CT scans can be large. Both
Dzhugashvili et al. [20] and Yang et al. [21] also reported
interobserver variability (similar to the results presented
here) in the delineation of the TB based on clips. These
results can be explained by the fact that tissue stranding
from the surgical cavity, proximity to muscle, dense breast
parenchyma, and benign calcifications may be mistaken
for surgical clips. Moreover, limited soft-tissue contrast on
CT makes it an unreliable modality for detecting a layer of
the image lacking surgical clips and when distinguishing
between surgically induced densities and normal glandular
breast tissue. Finally, the experience of the radiation
oncologist and subjective determination of the location
of the post-surgical cavity contribute to interobserver
variability. Using a combination of information to more
precisely define the TB, such as surgical reports, clinical
palpation of the surgical defect and CT-based planning,
may decrease interobserver variability. Additionally, clear
communication between the surgeon and radiotherapist,
including diagrammatic explanations, are crucial for ac-
curately targeting the TB.
Cover et al. [22] reported that when the EE phase was
reviewed in the sagittal plane, gating would reduce the
mean tumour mobility from 6.3 ± 2.0 mm to 1.4 ± 0.5 mm.
Moreover, 4DCT simulation scan can reduce motion
artefacts [23,24]. Therefore, to investigate spatial mis-
matches of interobserver variability in the delineation
of the TB based on different markers, the difference be-
tween the MDC, MDS and MDC+S were further analysedand compared based on the end-exhalation phase. Our
study found interobserver variability between the MDC,
MDS and MDC+S, as well as between the MDc and MDs,
MDC and MDC+S, and MDS and MDC+S. Our results
suggest spatial mismatch existed among observers in
the delineation of the TB based on clips, the seroma, both
the clips and seroma. Additionally, the MD of the seroma
was larger than that of the clips as well as both the clips
and seroma, and the MD of both the clips and seroma
was larger than that of the clips alone (Table 4). However,
the average CI reported by van Mourik et al. [16] was
0.53, which was considerably higher than that in the
present study. This difference is likely due to differing
target volume and calculation methods. Landis et al. [8]
and Li et al. [25] reported even higher CI values ranging
from 0.73-0.75; however this analysis focused on the PTV
instead of the TB, the CI of which increases due to the
larger volumes.
Image-guided techniques can improve clip and seroma
localisation during treatment, potentially enabling the
use of a smaller GTV-to-PTV margin. Ultrasound image
guidance has also been investigated [26]. However, it is
unclear if the margin is sufficient to account for interob-
server contour variability. Further studies are needed to
determine, whether contouring variability could result in
an underdosing of the clips or seroma. Thus, it is impera-
tive that future studies aiming to reduce margins from
current treatment practice take interobserver contour
variability into consideration.Conclusions
The results of our study suggest that interobserver vari-
ability is smaller in the 4DCT delineation of the TB based
on seroma compared with clips or both clips and seroma
when the SCS was 3 ~ 5 points and the number of surgical
clips was ≥5 in the lumpectomy cavity. Interobserver
volume differences were observed between the TBs de-
lineated based on surgical clips, and those delineated
based on both the clips and seroma. This was also the
case for spatial mismatch (MD), which was measured and
analysed at the end-expiration phase. Optimising the time
from lumpectomy to 4DCT scan is necessary to minimise
interobserver variability in the delineation of the TB. If the
time from lumpectomy to 4DCT simulation scan could be
appropriately chosen, the delineation of the target volume
based on seroma may be more reasonable in radiotherapy
treatment planning.Abbreviations
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